Llwytho...
Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia
Despite advances in the understanding of disease pathobiology, treatment for relapsed or refractory acute myeloid leukemia (R/R AML) remains challenging. The prognosis of R/R AML remains extremely poor despite chemotherapy and bone marrow transplants. Discoveries on recurrent and novel genetic mutat...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Bosn J Basic Med Sci |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292864/ https://ncbi.nlm.nih.gov/pubmed/33577442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2020.5485 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|